Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 7
2015 25
2016 19
2017 16
2018 13
2019 8
2020 9
2021 6
2022 12
2023 12
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic phenotype of bladder cancer.
Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R. Massari F, et al. Among authors: ciccarese c. Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8. Cancer Treat Rev. 2016. PMID: 26975021 Free article. Review.
2023 ASCO genitourinary cancers symposium: focus on renal cell carcinoma.
Anghelone A, Strusi A, Scala A, Panebianco M, Ciccarese C, Iacovelli R. Anghelone A, et al. Among authors: ciccarese c. Expert Rev Anticancer Ther. 2023 Jul;23(7):669-672. doi: 10.1080/14737140.2023.2218091. Epub 2023 May 29. Expert Rev Anticancer Ther. 2023. PMID: 37246571
Urinary Biomarkers for Prostate Cancer.
Giunchi F, Ciccarese C, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Moch H, Massari F, Fiorentino M. Giunchi F, et al. Among authors: ciccarese c. Curr Drug Metab. 2017 Oct 16;18(8):723-726. doi: 10.2174/1389200218666170518161140. Curr Drug Metab. 2017. PMID: 28524004 Review.
Circulating tumor cells in genitourinary tumors.
Massari F, Di Nunno V, Comito F, Cubelli M, Ciccarese C, Iacovelli R, Fiorentino M, Montironi R, Ardizzoni A. Massari F, et al. Among authors: ciccarese c. Ther Adv Urol. 2017 Nov 22;10(2):65-77. doi: 10.1177/1756287217742564. eCollection 2018 Feb. Ther Adv Urol. 2017. PMID: 29434674 Free PMC article. Review.
Metabolic alterations in renal cell carcinoma.
Massari F, Ciccarese C, Santoni M, Brunelli M, Piva F, Modena A, Bimbatti D, Fantinel E, Santini D, Cheng L, Cascinu S, Montironi R, Tortora G. Massari F, et al. Among authors: ciccarese c. Cancer Treat Rev. 2015 Nov;41(9):767-76. doi: 10.1016/j.ctrv.2015.07.002. Epub 2015 Jul 9. Cancer Treat Rev. 2015. PMID: 26169313 Review.
2023 ASCO Genitourinary Cancers Symposium: a focus on urothelial carcinoma.
Cigliola A, Beccia V, Anghelone A, Panebianco M, Ciccarese C, Iacovelli R. Cigliola A, et al. Among authors: ciccarese c. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(11):1123-1126. doi: 10.1080/14737140.2023.2265570. Epub 2023 Oct 27. Expert Rev Anticancer Ther. 2023. PMID: 37781991
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Procopio G, Claps M, Pircher C, Porcu L, Sepe P, Guadalupi V, De Giorgi U, Bimbatti D, Nolè F, Carrozza F, Buti S, Iacovelli R, Ciccarese C, Masini C, Baldessari C, Doni L, Cusmai A, Gernone A, Scagliarini S, Pignata S, de Braud F, Verzoni E. Procopio G, et al. Among authors: ciccarese c. Tumori. 2023 Feb;109(1):129-137. doi: 10.1177/03008916221138881. Epub 2022 Nov 29. Tumori. 2023. PMID: 36447337 Free PMC article. Clinical Trial.
122 results